The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease

Document Type

Article

Abstract

Dysfunction of nerve growth factor (NGF) and its high (TrkA) and low (p75NTR) affinity receptors has been suggested to underlie the selective degeneration of the nucleus basalis (NB) cholinergic cortical projection neurons in end stage Alzheimer disease (AD). Whether the NGF system is dysfunctional during the prodromal stages of AD has only recently been evaluated. Surprisingly, the number of choline aceryltransferase-containing neurons remains stable despite a significant reduction in NGF receptor-positive cells in people with mild cognitive impairment (MCI), suggesting a phenotypic NGF receptor downregulation but not a frank loss of NB neurons during prodromal AD. Moreover, there is a loss of cortical TrkA in the face of stable p75 NTR and increased proNGF levels, the precursor molecule of mature NGF, in early AD. Depending upon the cellular context these changes may result in increased pro-apoptotic signaling, cell survival, or a defect in retrograde transport mechanisms. Alterations in NGF and its receptors within the cholinotrophic NB system in early AD suggest that NGF-mediated cell signaling is required for the long-term survival of these neurons. Therapeutic neurotrophic intervention might delay or prevent NB neuron degeneration and preserve cholinergic cortical function during prodromal AD. Copyright © 2005 by the American Association of Neuropathologists, Inc.

Keywords

Alzheimer disease, Cholinergic, Nerve growth factor receptor, Neurotrophin, Nucleus basalis, Therapy

Publication Date

1-1-2005

Publication Title

Journal of Neuropathology and Experimental Neurology

ISSN

00223069

Volume

64

Issue

4

First Page

263

Last Page

272

PubMed ID

15835262

Digital Object Identifier (DOI)

10.1093/jnen/64.4.263

Link to Full Text

Share

COinS